HopeStage
Back to all studies
RecruitingNCT06323824

Office-based methadone or buprenorphine for opioid-use treatment

About this title

Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

Read the official source — NCT06323824
Medication studyAges 18–99United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 99 years.

Listed locations
Oakland and 5 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 4, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
600
Sponsor
Yale University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 99 Years
Official registry ID
NCT06323824
Official title
Show the full official title

Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment - A Pragmatic Hybrid Effectiveness/Implementation Trial

Recruitment & locations

Currently recruiting

Oakland · San Francisco · Denver

3 more locations
  • Boston
  • Minneapolis
  • Huntington

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University, a university.

Does this study involve medication?

Yes. The study involves medication, including Methadone and Buprenorphine (BUP).

Who can participate?

Listed age limits: 18 years to 99 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies